Yue Wang

2.9k total citations
137 papers, 2.2k citations indexed

About

Yue Wang is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Yue Wang has authored 137 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 33 papers in Oncology and 28 papers in Hematology. Recurrent topics in Yue Wang's work include Metal complexes synthesis and properties (19 papers), Acute Myeloid Leukemia Research (18 papers) and Nanoparticle-Based Drug Delivery (17 papers). Yue Wang is often cited by papers focused on Metal complexes synthesis and properties (19 papers), Acute Myeloid Leukemia Research (18 papers) and Nanoparticle-Based Drug Delivery (17 papers). Yue Wang collaborates with scholars based in China, United States and Japan. Yue Wang's co-authors include Nobuo Okabe, Robert H. Carter, Tao Lu, Guowu Lin, Tao Lu, Shuo Liu, Guangxuan Liu, Jeffrey W. Taub, Holly Edwards and Yubin Ge and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Yue Wang

127 papers receiving 2.1k citations

Peers

Yue Wang

ONCOL

IMMUN

HEMAT

BIOMA

Bastiaan Nuijen Netherlands

Cai Yuan China

Thomas Mueller Germany

Peipei Xu China

Ana Cristina Gonçalves Portugal

Darrell Sleep United Kingdom

Anant Narayan Bhatt India

Tao Yi China

Jan Hraběta Czechia

Qin Lu China

Bastiaan Nuijen Netherlands

Yue Wang

1.0k ×1.1

829 ×2.0

ONCOL

340 ×0.8

IMMUN

150 ×0.5

HEMAT

396 ×1.3

BIOMA

Citations per year, relative to Yue Wang Yue Wang (= 1×) peers Bastiaan Nuijen

Countries citing papers authored by Yue Wang

Since Specialization

Citations

This map shows the geographic impact of Yue Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue Wang more than expected).

Fields of papers citing papers by Yue Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yue Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue Wang. The network helps show where Yue Wang may publish in the future.

Co-authorship network of co-authors of Yue Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yue Wang. A scholar is included among the top collaborators of Yue Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yue Wang. Yue Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yue, et al.. (2026). Flexible crosslinked collagen membranes with self-reinforcing effect for corneal repair. Chemical Engineering Journal. 529. 172798–172798.

Liu, Siyu, et al.. (2025). CD44-Targeted Gold-Nanorod-Based Nano-adjuvant Combining Mild Photothermal Therapy and Immune Activation for Triple-Negative Breast Cancer Therapy. ACS Applied Nano Materials. 8(32). 16040–16052. 1 indexed citations

Liao, Zhenrui, Yu Jiang, Fei Liang, et al.. (2025). Nanovaccine enables complement system inhibition and high-dose AAV re-administration. Chemical Engineering Journal. 507. 160810–160810. 1 indexed citations

Cai, Junchao, Xiangshu Cheng, Changmei Chen, et al.. (2025). Near-infrared threonine-quercetin carbon dots for bioimaging and dual protection against liver and brain injury via oral and intravenous administration. Chemical Engineering Journal. 512. 162676–162676. 5 indexed citations

Xue, Zhaoli, et al.. (2025). Metal ions control configuration and ¹O₂ generation capacity of hexaphyrin(2.1.2.1.2.1) with embedded benzene. Dalton Transactions. 54(13). 5255–5258. 5 indexed citations

Shi, Furong, et al.. (2024). Systematic Investigation of indole-based BODIPYs: Synthesis, Dual-State Emission, singlet oxygen formation. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 328. 125461–125461.

Zhang, Jiahao, Siyu Liu, Yufeng Sun, et al.. (2024). Nanosized Porphyrin-Containing Covalent Organic Polymer to Enhance Ferroptosis in Photodynamic Treatment of Tumor Cells via Glutathione Depletion. Bioconjugate Chemistry. 35(9). 1450–1458.

Sun, Yufeng, et al.. (2024). 4T1 Cell Membrane Biomimetic Nanovehicle for Enhanced Breast Cancer Treatment. ACS Medicinal Chemistry Letters. 16(1). 51–58. 5 indexed citations

Liu, Xiaoqiong, Lingling Fan, Jian Li, et al.. (2023). Mailuoning oral liquid attenuates convalescent cerebral ischemia by inhibiting AMPK/mTOR-associated apoptosis and promoting CREB/BDNF-mediated neuroprotection. Journal of Ethnopharmacology. 317. 116731–116731. 13 indexed citations

10.

Hu, Shuo, et al.. (2023). Green Synthesis of Anti-bacterial Nano Silver by Polysaccharide from Bletilla Striata. Inorganics. 11(1). 40–40. 7 indexed citations

11.

Zhi, Yanle, Hongmei Li, Qiaomei Jin, et al.. (2023). Rational design of 4-((6-phenoxypyrimidin-4-yl)amino)-N-(4-(piperazin-1-yl)phenyl)-1H-pyrazole-3-carboxamide (LT-540-717) as orally bioavailable FLT3 inhibitor. European Journal of Medicinal Chemistry. 256. 115448–115448. 5 indexed citations

12.

Dong, Zhipeng, Jiahao Zhang, Jun Luo, et al.. (2022). Dendritic polyethylene glycol-modified folate–nickel nanotubes as an efficient antitumor nano-metal medicine. Journal of Materials Science. 57(37). 17751–17764.

13.

Edwards, Holly, Deying Wang, Shuang Liu, et al.. (2022). Inhibition of Mcl-1 Synergistically Enhances the Antileukemic Activity of Gilteritinib and MRX-2843 in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia. Cells. 11(17). 2752–2752. 5 indexed citations

14.

Ma, Jun, Tristan Knight, Yongwei Su, et al.. (2021). The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML. Blood Cancer Journal. 11(6). 111–111. 27 indexed citations

15.

Zhang, Ni, Yue Wang, Changchang Zhang, et al.. (2020). LDH-stabilized ultrasmall iron oxide nanoparticles as a platform for hyaluronidase-promoted MR imaging and chemotherapy of tumors. Theranostics. 10(6). 2791–2802. 45 indexed citations

16.

Ma, Jun, Tristan Knight, Holly Edwards, et al.. (2019). Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia. Clinical Cancer Research. 25(22). 6815–6826. 117 indexed citations

17.

Wang, Yue, Yanle Zhi, Qiaomei Jin, et al.. (2018). Discovery of 4-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide (FN-1501), an FLT3- and CDK-Kinase Inhibitor with Potentially High Efficiency against Acute Myelocytic Leukemia. Journal of Medicinal Chemistry. 61(4). 1499–1518. 89 indexed citations

18.

Xiao, Na, et al.. (2017). De Novo Computational Design for Development of a Peptide Ligand Oriented to VEGFR-3 with High Affinity and Long Circulation. Molecular Pharmaceutics. 14(7). 2236–2244. 14 indexed citations

19.

Zhao, Wei, Yue Wang, Maureen A. Sartor, et al.. (2012). An Integrated Genome-Wide Approach to Discover Tumor-Specific Antigens as Potential Immunologic and Clinical Targets in Cancer. Cancer Research. 72(24). 6351–6361. 22 indexed citations

20.

Xu, Yinyan, Yoshiyuki Takahashi, Yue Wang, et al.. (2009). Downregulation of GATA-2 and overexpression of adipogenic gene-PPARγ in mesenchymal stem cells from patients with aplastic anemia. Experimental Hematology. 37(12). 1393–1399. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact